Live market screen
Commercial Space Company Risk / Opportunity Ranking
Opportunity/risk view across launch, satellites, SAR, earth observation, defense demand, financing events, and execution risk.
Updated June 27, 2026
Opportunity view
Showing rows 61-80 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 61 | Isar Aerospace mediummedium | Opp 5 Risk 4 | Thesis: Isar Aerospace has the clearest recent opportunity setup in this screen: a June 2026 article summary says it raised €270 million ($312 million), has total capital near €1 billion excluding ESA support, and scheduled a Spectrum launch window for June 15-21 from Norway. If execution succeeds, the article frames it as a milestone for European commercial launch capability. Why now: Recent supporting article context within the recent evidence window supports timing: is dated June 9, 2026 and states Isar raised €270 million and had a June 15-21 Spectrum launch window from Andoya. Date basis is source date. Evidence
Caveats: Evidence is supporting article context only and appears under weak context, not direct dated events. Positive and risk interpretations come from the same article and are not independent confirmation. |
| 62 | K2 Space mediummedium | Opp 5 Risk 2 | Thesis: K2 Space has a credible 1 year+ opportunity setup because a dated June 11, 2026 article says it landed a key supplier role in the U.S. Space Force's next-generation military communications network and will provide the satellite platform for SES's PTS-G program, which could support longer-cycle strategic relevance and follow-on demand if execution proceeds. Why now: The evidence is recent within the 90-day recent evidence window and dated June 11, 2026 on a source date basis, which fits a 1 year+ horizon because supplier-role wins in defense satcom can matter over a longer program cycle if they convert into execution and revenue-bearing milestones. Evidence
Caveats: Available support is supporting article context with neutral polarity, not direct structured positive event/fact evidence. Only one dated article remains within the recent evidence window; same-article repeated rows are not independent confirmation. |
| 63 | Millennium Space Systems mediummedium | Opp 5 Risk 4 | Thesis: Millennium Space Systems has a positive long-horizon signal from being named among companies awarded Space Force Andromeda contracts tied to geosynchronous reconnaissance and surveillance satellites, indicating program access in a strategically relevant segment. Why now: The relevant evidence is within the recent evidence window: an April 8, 2026 article said the U.S. Space Force awarded 14 companies more than $1.8 billion in Andromeda contracts and included Boeing's Millennium Space Systems, which is potentially durable over a 1 year+ horizon if tasking converts into meaningful work Evidence
Caveats: Evidence is supporting article context, not a company-specific contract award document or structured positive event row. Reviewed evidence does not show Millennium's individual award size or share of the ceiling value. Same article repeated in weak-context rows is not independent confirmation. |
| 64 | Northwood Space mediumweak | Opp 5 Risk 2 | Thesis: Northwood Space has the clearest reviewed sources-supported opportunity among the smaller private names because the reviewed sources directly says it has a Space Force contract and a factory tied to optical ground stations, which supports durable government-linked space infrastructure relevance over a 1 year+ horizon. Why now: The reviewed sources' membership rationale explicitly anchors current relevance to a Space Force contract and factory buildout tied to optical ground stations, citing article, though the article is not supplied in the reviewed sources. Caveats: No representative article object or is included despite the cited article ID. Single-article support limits conviction. |
| 65 | Orion Space Solutions mediummedium | Opp 5 Risk 2 | Thesis: Orion Space Solutions has meaningful contract-backed business activity within the recent evidence window, with initial contracts over $24 million, over 25 payloads, multi-year execution scope, and total potential value above $100 million if batch deliveries complete. Why now: A representative article dated March 29, 2026 states Orion Space Solutions won initial contracts worth over $24 million to build more than 25 advanced payloads, with total potential value over $100 million and multi-year design, manufacturing, testing, and calibration work, which can matter over a 1 year+ horizon Evidence
Caveats: This is supporting article context and explicitly weaker than direct structured company-event evidence. The customer is undisclosed. Only one article is retained; same-article repetition is not independent confirmation. |
| 66 | OroraTech mediummedium | Opp 5 Risk 2 | Thesis: OroraTech shows moderate long-horizon opportunity because a dated May 4, 2026 article reports deployment of four proprietary wildfire-detection satellites for Greece as part of an operational sovereign system, suggesting real product deployment, country-level adoption, and vertically integrated execution from satellites through data processing. Why now: A dated article with May 4, 2026 states that four satellites in the Hellenic Fire System launched and deployed on May 3, making Greece the first country with a sovereign operational wildfire-detection constellation; for a 1 year+ horizon, that kind of operational deployment can matter as a proof point for follow-on adoption if it persists Evidence
Caveats: The available evidence is weak context/supporting article context, not stronger company-specific events. Same article supplies the key claims, so this is not independent confirmation. No material adverse evidence is available, but absence of risk evidence is not proof of low risk. |
| 67 | RapidTek lowweak | Opp 5 Risk 3 | Thesis: Relatively better opportunity within these reviewed sources: the membership rationale says RapidTek successfully connected its Black Kite-2 8U CubeSat with ground stations and aims for a LEO IoT network. That is a concrete technical milestone with a plausible 1 year+ commercialization pathway if network development continues. Why now: Why now is the reported successful satellite-ground connection and stated LEO IoT ambition referenced in article ID, though the reviewed sources does not include the article or exact timing details. Caveats: The technical milestone is described only in membership rationale, not available direct evidence. Article ID has no in the reviewed sources. Technical connectivity milestone is weaker than contracted commercial deployment. |
| 68 | Skyroot Aerospace mediummedium | Opp 5 Risk 4 | Thesis: Skyroot has a credible long-horizon opportunity case from recent financing and launcher milestone positioning: Fortune India says it raised nearly $60 million at a $1.1 billion pre-money valuation and is preparing for the maiden flight of Vikram-1, its orbital launch vehicle. Why now: The relevant dated development is the reported financing on May 7, 2026 alongside the stated approach to the Vikram-1 maiden flight, which fits a 1 year+ thesis if execution progresses. Evidence
Caveats: Support is supporting article context only; the reviewed sources have no direct positive events available for Skyroot. Same-article repeated context rows are not independent confirmation. |
| 69 | Spark Space mediummedium | Opp 5 Risk 5 | Thesis: Spark Space has a credible speculative opportunity because supporting article context says it tested an engine and raised funds for an electric-pump rocket, which are relevant proof points for an early launch company over a 1 year+ horizon. Why now: The reviewed sources retains undated evidence indicating Spark Space tested its engine and raised funds for an electric-pump rocket, but the article has no publication timestamp, so recency-sensitive claims should be treated cautiously. Evidence
Caveats: Article is undated, so business-state recency is uncertain. Evidence is supporting article context, not direct dated event/facts. Same article appears twice in weak-context rows and is not independent confirmation. |
| 70 | Stellar Alpina AG lowweak | Opp 5 Risk 4 | Thesis: The reviewed sources' membership rationale states Stellar Alpina is a Swiss space startup that raised CHF 3.5M pre-seed and is developing rotating detonation rocket engines for in-space mobility. For a 1 year+ horizon, recent financing plus differentiated propulsion development creates meaningful upside optionality. Why now: Why now is relatively better than peers because the rationale includes a recent capital raise and a specific product focus, both of which can influence a 1 year+ strategic trajectory, though no direct dated evidence are available to verify recency sequencing. Caveats: Membership rationale cites article IDs: and: but no are present. The reviewed sources contain no direct positive or negative evidence arrays despite the financing statement in the rationale. Early-stage propulsion development is inherently high-uncertainty, but that is inferred from stage and product type, not from a available adverse article. |
| 71 | The Exploration Company lowweak | Opp 5 Risk 2 | Thesis: Moderate long-horizon opportunity based on article-context evidence that the company won an ESA cargo return service contract and was ranked first in the competition, which suggests external validation and potential programmatic traction if still current. Why now: Why now is weak: the only cited catalyst is an undated article stating the company won an ESA cargo contract, and the reviewed sources provide no newer dated confirmation within the 90-day window. Recency-sensitive conclusions should therefore be cautious. Evidence
Caveats: Only undated article-context evidence is present; no direct structured positive event/facts survived. The reviewed sources includes no within the recent evidence window dated follow-up on financing, program execution, or milestone delivery. Article-level context is weaker than direct company event/fact evidence. |
| 72 | Tomorrow.io lowweak | Opp 5 Risk 4 | Thesis: The reviewed sources membership rationale states Tomorrow.io raised an additional $35M, bringing its Series F to $210M, for the DeepSky AI-native satellite constellation, which supports a moderate long-horizon opportunity thesis around financing-backed constellation buildout and commercialization. Why now: The 'why now' is the capital raise described in the reviewed sources' membership rationale via article: but the ranking payload does not include the article or a richer reviewed evidence row, so recency and detail are only partially grounded. Evidence
Caveats: The reviewed sources does not provide the article for the cited membership-support article. This is mainly a financing-backed opportunity thesis, not a contract- or revenue-backed one in these reviewed sources. |
| 73 | Transcelestial lowweak | Opp 5 Risk 4 | Thesis: The reviewed sources membership rationale describes Transcelestial as a private lasercom startup aiming for a LEO constellation and having a partnership to advance optical communications architecture in LEO. If current, that supports a durable 1 year+ opportunity tied to optical communications buildout. Why now: Why now is only moderate because the membership rationale references support references including, and: but the reviewed sources does not provide or article summaries for them. Without visible dated article detail, the near-current business state cannot be confirmed. Caveats: Important claims appear only in the membership rationale; no -bearing direct evidence is exposed. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. |
| 74 | Umbra mediummedium | Opp 5 Risk 2 | Thesis: Umbra has a moderate long-horizon opportunity case because a dated June 22, 2026 article describes it as a U.S. commercial space company developing and operating a SAR satellite constellation that delivers rapid, regular, high-resolution data to public and private customers, suggesting an already-operational capability base that could support durable growth over a 1 year+ horizon. Why now: The most recent dated context is June 22, 2026, which is within the 90-day recent evidence window and indicates Umbra currently operates a SAR constellation and serves government and commercial customers. However, no nearer-term catalyst row is available, so the timing case is moderate rather than strong. Evidence
Caveats: Evidence is supporting article context/weak context only, not a direct structured positive event row. The July 31, 2024 Umbra article is outside the 90-day dated recent evidence window and was dropped for recency-sensitive scoring. |
| 75 | Unastella lowweak | Opp 5 Risk 4 | Thesis: The reviewed sources say Unastella is a South Korean startup developing small satellite launch vehicles, has raised a Series B, and successfully launched Una Express-I. That combination of financing and a successful launch milestone is one of the clearer long-horizon opportunity setups in this screen, if current. Why now: Why now is relatively stronger because the rationale includes both funding and a technical milestone, which are durable indicators for a 1 year+ horizon, though exact dates and chronology cannot be checked from the reviewed sources' empty post-recent evidence window evidence tables. Caveats: Membership rationale cites article IDs: and: but no are given. No direct events or summaries are available after recent evidence window, so success claims cannot be quoted from the reviewed sources. Opportunity and risk both reflect a capital-intensive launch model with limited reviewed sources verification. |
| 76 | Univity lowweak | Opp 5 Risk 4 | Thesis: Best-supported opportunity in this sparse batch: the reviewed sources membership rationale says Univity raised $32M to build a European satellite network rivaling Starlink, which is a direct financing-and-buildout claim that can matter over a 1 year+ horizon if execution continues. Why now: Why now is the claimed funding event and network build plan referenced in article ID: but the reviewed sources does not provide the article or detailed timestamp, so recency is only partially grounded. Caveats: The key claim comes from membership rationale rather than available direct evidence. Article ID: is referenced without a. No evidence of downstream execution, contracts, launches, or adoption is present. |
| 77 | Vantor lowweak | Opp 5 Risk 4 | Thesis: The reviewed sources membership rationale describes potentially material traction: Vantor is described as having won a $70M NGA GEOINT platform contract, additional NGA Luno B contracts for orbital intelligence and AI change detection, and plans satellite constellation expansion, which would support a multi-quarter opportunity thesis if confirmed in article detail. Why now: Why now is only moderate because the membership rationale references significant contracts via support references including: but the reviewed sources provide no or representative article detail for citation-quality corroboration. The forecast horizon of 1 year+ could fit contract conversion and constellation expansion if current, but recency cannot be validated from visible article rows. Caveats: The contract and expansion claims appear only in membership rationale text; no representative article with is included. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. |
| 78 | Albedo lowweak | Opp 4 Risk 4 | Thesis: Albedo has the clearest dated recency in the reviewed sources: an external article states the company announced plans on April 9 to send its second spacecraft and is preparing a second VLEO mission for 2027 launch, which suggests continued program progression over a 1 year+ horizon Why now: Why now is stronger than for most names because the reviewed sources includes a dated representative article with April 9, 2026, stating that on April 9 Albedo announced plans for its second spacecraft and a 2027 launch for its second VLEO mission Evidence
Caveats: The reviewed sources marks this as weak context only / supporting article context, not strong direct event evidence. Same article appears in multiple weak-context rows and should not be treated as independent confirmation. |
| 79 | Apogeo Space lowweak | Opp 4 Risk 2 | Thesis: Apogeo Space has moderate long-horizon opportunity on reviewed sources evidence because it is described as having a ground-station integration agreement and technical collaboration on CubeSat platforms, payloads, and joint missions, indicating active ecosystem positioning in space infrastructure and services. Why now: The reviewed sources' membership rationale cites article: for the integration agreement and technical collaboration, but no article or direct evidence are included. Caveats: Evidence is thin and article-level details are missing. Collaboration and integration agreements are weaker than revenue-bearing customer wins. Single-article support limits conviction. |
| 80 | Astranis lowmedium | Opp 4 Risk 2 | Thesis: Astranis has recent supporting article context indicating both contract relevance and financing support: it was included among companies awarded Space Force Andromeda contracts on April 8, 2026 and was reported to have raised a $300 million Series E on June 19, 2026, which supports a longer-horizon capacity and program participation thesis. Why now: Recent dated context within the 90-day recent evidence window points to fresh financing and government program inclusion, both relevant for a 1 year+ horizon: Andromeda context on April 8, 2026 and funding context on June 19, 2026 Evidence
Caveats: Evidence is mainly supporting article context, which is weaker than direct event/fact evidence. An older 2025 article about a 2027 transportation deal exists, but it is outside the recent evidence window and not used as current proof. |
Risk view
Showing rows 241-260 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 241 | AEVEX Corp. lowweak | Opp 1 Risk 1 | Thesis: No direct negative evidence is available in the reviewed sources; the main limitation is insufficient company-specific proof of role, traction, or adversity. Why now: There is no reviewed sources-grounded catalyst or timing support for a 1 year+ thesis. The reviewed sources references article id: but provides no, quote, or retained evidence row. Caveats: Sector/SPAC mention is supporting article context and weaker than direct company-specific events or facts. No representative article summary or is present for direct citation. Low scores reflect sparse evidence, not a strong directional view. |
| 242 | Agnikul Cosmos lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is provided within the reviewed sources for the selected recent evidence window, so a negative thesis is also unsupported. Why now: Why now is unsupported because the reviewed sources show zero evidence after recent evidence filtering despite many articles considered; recency-specific business state cannot be established from the provided evidence. Caveats: Coverage debug shows zero evidence after recent evidence filtering. Membership rationale cannot substitute for cited directional evidence under the output rules. Absence of evidence is not positive or negative proof. |
| 243 | Airbus SE lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources does not provide material adverse company-specific evidence within the recent evidence window, so risk is low on reviewed sources evidence but not affirmatively cleared. Why now: There is no within the recent evidence window evidence available for Airbus; the only cited article is older context published March 4, 2025, outside the 90-day cutoff noted by the reviewed sources, so recency support is weak. Caveats: Coverage after recent evidence window is effectively empty: articles after recent evidence window is 0. The available Airbus article is contextual and outside the 90-day recent evidence window. Cohort membership does not establish attractiveness. |
| 244 | Alta Ares lowweak | Opp 1 Risk 1 | Thesis: No material adverse thesis is supportable because the retained reviewed sources contain no direct negative evidence after recent evidence window. Why now: Why now is weak: the reviewed sources show no retained evidence after recent evidence window, and the membership rationale says Alta Ares appears only in a broad funding roundup without enough company-specific detail. Caveats: Phase-2 membership rationale references: but no article summary or direct retained evidence is available here for factual use. The reviewed sources itself says company-specific detail is insufficient. |
| 245 | Altamira Technologies Corporation lowweak | Opp 1 Risk 1 | Thesis: No material adverse thesis is supportable because the reviewed sources does not provide direct negative evidence for Altamira in the scoring section. Why now: The phase2 rationale notes only that Parsons acquired Altamira and references defense/national security themes, but no citable evidence are provided here. Coverage data shows zero articles after recent evidence window and zero evidence available. Caveats: Ownership/acquisition context alone is not enough without direct evidence detail. No dated catalyst evidence is surfaced in the reviewed sources. |
| 246 | Amazon.com Inc. lowweak | Opp 1 Risk 1 | Thesis: No direct adverse space-related evidence is available in the reviewed sources for Amazon within the recent evidence window. Why now: No current catalyst can be established from the available evidence because post-recent evidence window evidence are absent. Caveats: Extremely large mention universe is not conviction. No usable evidence were available after recent evidence window. |
| 247 | AnduraX lowweak | Opp 1 Risk 1 | Thesis: No retained within the recent evidence window negative evidence is available, so a risk thesis is not evidence-supported in these reviewed sources. Why now: There is no retained article or evidence row after the 90-day recent evidence window, so the reviewed sources does not establish a current catalyst or updated business state. Caveats: Coverage is effectively empty after recent evidence window: articles after recent evidence window = 0 and evidence after recent evidence window = 0. Membership rationale references article IDs, and: but no or retained summaries are provided here. Scores remain low because positive or negative direction cannot be grounded with citable retained evidence. |
| 248 | Angkasa-X Holdings Corp. lowweak | Opp 1 Risk 1 | Thesis: No retained within the recent evidence window direct negative evidence is provided in the reviewed sources, so there is not enough support for a material adverse thesis either. Why now: There is no usable within the recent evidence window article evidence available for ranking; coverage data shows zero article IDs after recent evidence window and zero evidence after recent evidence window, so recency-sensitive judgment is not possible from these reviewed sources alone. Caveats: Reviewed evidence notes one considered article for membership support but zero article IDs after recent evidence window and zero available evidence after recent evidence window, so ranking is constrained by evidence absence rather than business absence. Membership rationale references article: but the reviewed sources does not provide the article or a retained within the recent evidence window evidence row for ranking use. |
| 249 | Antaris Inc. lowweak | Opp 2 Risk 1 | Thesis: No material adverse thesis is supported because no direct negative evidence are provided. Why now: Why now is weak: the only reviewed sources signal is the phase2 rationale mentioning a post-Series A portfolio reference tied to article, but no representative article summary or direct evidence row is included here to establish timing or business impact. Caveats: The cited Series A context appears only in phase2 rationale rather than in stronger scoring evidence fields. No product, customer, or execution evidence is provided. |
| 250 | Applied Aerospace & Defense Inc. lowweak | Opp 1 Risk 1 | Thesis: There is also insufficient material adverse evidence in the reviewed sources to support a negative thesis. The lack of direct evidence is uncertainty, not a demonstrated business risk. Why now: Why now is weak because the reviewed sources show zero evidence available after the 90-day recent evidence window cutoff date of March 29, 2026, so recency-based catalysts cannot be established from these reviewed sources. Caveats: No current evidence is provided for cited Evidence rows available after recent evidence window: 0. Mention as competition or IPO context is weaker than direct company event evidence. |
| 251 | ArianeGroup lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources provide no direct negative evidence, so no adverse thesis is supportable from this evidence set. Why now: The phase2 rationale references Ariane 6/Arianespace launch context for Amazon Kuiper, but relation/context evidence cannot be used as counterparty propagation and no direct evidence is exposed in the scoring fields. Coverage data shows zero articles after recent evidence window and zero evidence available. Caveats: Do not use context-only relation logic as direct thesis proof. No direct company-specific event evidence is included here. |
| 252 | Arxis, Inc. lowweak | Opp 1 Risk 1 | Thesis: No material adverse thesis is supported within the retained 90-day evidence window; there is also no direct negative evidence available for Arxis. Why now: Why now is unclear because coverage data shows 0 articles after recent evidence window and 0 evidence after recent evidence window, so there is no retained recent catalyst evidence in the reviewed sources. Caveats: Reviewed evidence cites membership support from, but no representative article is provided, so the underlying claim cannot be restated as direct scored evidence with. Coverage after recent evidence window is empty, limiting conviction. |
| 253 | Arxis Inc. lowweak | Opp 1 Risk 1 | Thesis: No material adverse thesis is supportable from the retained reviewed sources evidence because no direct negative evidence survived the 90-day recent evidence window. Why now: Why now is weak: the reviewed sources show zero evidence after recent evidence window for Arxis Inc., so there is no current catalyst or current business-state proof in the retained record. Caveats: Coverage after recent evidence window is empty for this company. Phase-2 membership rationale references support references including: but no article summary or quoted evidence is included in the retained reviewed sources, so it cannot be used for factual claims here. |
| 254 | Aselsan lowweak | Opp 1 Risk 1 | Thesis: No retained in-recent evidence window evidence supports a current adverse thesis. Why now: The reviewed sources retained zero evidence after the 90-day cutoff, so there is no current catalyst evidence for the 1 year+ ranking despite article-based membership context. Caveats: Membership rationale cites article, but no article summary or retained evidence row is available here. 24 articles were considered, but none remained after recent evidence filtering. |
| 255 | Astranis Space Technologies lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is available in the reviewed sources. Why now: No retained article or facts remain in the reviewed sources after recent evidence window, so timing and durability cannot be judged from local evidence. Caveats: Opportunity view depends on uncited membership rationale rather than retained evidence. No recency-confirmed direct evidence in reviewed sources. |
| 256 | Astro Digital lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is available. Risk remains low but non-zero because the company-specific operating picture is unestablished in retained evidence. Why now: No supported current catalyst. The reviewed sources explicitly warns this is counterparty context only, and coverage debug shows no retained evidence after recent evidence window. Caveats: No current evidence is provided for the cited support article in the reviewed sources. Counterparty context should not be treated as strong propagation evidence. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. |
| 257 | Astrobiome Space lowweak | Opp 1 Risk 1 | Thesis: No material risk thesis is supportable from retained evidence in these reviewed sources because no direct negative rows survive the recent evidence window. Why now: There is no retained evidence showing a current contract milestone, financing event, or product progress inside the recent evidence window. Caveats: Phase-2 rationale says Astrobiome Space contracted Redwire for a commercial space greenhouse/ISS agriculture mission and cites: and: but no or summaries are available here. Coverage debug shows 6 articles considered and 0 after recent evidence window. Relationship context should not be propagated as stronger evidence without direct retained event/facts. |
| 258 | Astrolight lowweak | Opp 2 Risk 1 | Thesis: The lack of retained direct evidence creates uncertainty around current contract scope, deployment status, and commercialization durability; no explicit negative evidence is available. Why now: Why now is weak because the reviewed sources cites support article: in membership rationale, but no, article summary, or retained evidence are provided after the 90-day filter. Caveats: Potentially strong fundamentals are only referenced in membership rationale without citable article details. Coverage data shows zero articles after recent evidence window and zero evidence after recent evidence window. Private-company status also limits external validation in these reviewed sources. |
| 259 | Astrome lowweak | Opp 2 Risk 1 | Thesis: No reviewed sources evidence points to material adverse developments. The constraint is evidentiary thinness, so risk remains low but uncertain. Why now: Why now is weak because the support exists only in the phase-2 rationale; coverage data shows zero evidence after recent evidence window, so timing and durability of the funding support cannot be verified from local evidence. Caveats: No direct article or event evidence is available after recent evidence window. Government-support statement is not accompanied by a dated in-window source in the reviewed sources. Low confidence due to sparse evidence. |
| 260 | Atomos Space lowweak | Opp 2 Risk 1 | Thesis: No material adverse evidence is present in the reviewed sources. Risk remains low-scored only because evidence is sparse, not because risk is disproven. Why now: Why now is limited and recency is uncertain: the only retained evidence is undated supporting context, so it cannot establish a fresh catalyst, only background relevance, article date_basis: undated). Evidence
Caveats: The evidence is undated, and the reviewed sources explicitly says to treat undated external evidence as relevance context rather than recency proof. The retained rows are weak context and neutral polarity, not positive evidence. Same article repeated rows are not independent confirmation. |